Results 11 to 20 of about 1,041 (148)
Evaluation of medication treatment for Alzheimer's disease on clinical evidence [PDF]
, 2014 Objective To formulate the best treatment plan for Alzheimer's disease patients by evaluating the therapeutic efficacy and side effect of various evidence-based programs.
Ling LIU +3 more
core +2 more sources
Zhongguo shiyan zhenduanxue, 2022 阿尔茨海默病(AD)是一种进行性认知功能障碍为核心的中枢神经系统变性病[1],患者不仅存在脑组织结构和功能的异常,还有脑分子代谢改变。阿尔茨海默病生物标志物是评估疾病病理生理学特征的客观量化指标[2],近年来NIA-AA[3]提出AT(N)研究框架,其将生物标志物β-淀粉样蛋白(Aβ)沉积(A)、
李佳霖 +5 more
doaj
Improvement Effect of Piceatannol on Cognitive Function of Mice with Alzheimer's Disease(白皮杉醇对阿尔茨海默病小鼠认知功能的改善作用) [PDF]
Shipin kexue jishu xuebao, 2023 To evaluate the improvement effect of piceatannol on cognitive impairment in Alzheimer's disease (AD) mice, seventy-two male Kunming mice were randomly divided into 6 groups with 12 mice in each group, including control group, model control group ...
YANG Wei(杨薇) +5 more
doaj +1 more source
Research progress of integrated stress response in pathogenesis of Alzheimer's disease [PDF]
, 2023 Integrated stress response (ISR) is a cellular adaptive response induced by stress, which is strictly regulated by multiple phosphokinases, phosphatases and other proteins to maintain protein homeostasis.
CHENG Weiwei +6 more
core +1 more source
Developments in the Role of Iron Imbalance in the Pathogenesis of Alzheimer's Disease [PDF]
, 2022 Iron load is closely associated with the initiation and progression of Alzheimer's disease (AD) . Although age-dependent deposition of β-amyloid (A β) in senile plaques (SPs) , and neurofibrillary tangles (NFTs) formed by accumulation ...
GUO Shuang, CHEN Fengyan, YIN Xiang, WANG Lu, GUO Xuefeng, YU Qiming, ZOU Zhenyou, SHU Wei
core +1 more source
CRMP2衍生的TAT-CBD3多肽对阿尔茨海默病神经元的保护作用
Zhongguo shiyan zhenduanxue, 2021 目的探索CRMP2衍生的TAT-CBD3多肽对AD大鼠神经元的保护作用及其机制。方法雄性Wistar大鼠随机分为假手术组(Sham)、模型组(Model)、TAT-CBD3高剂量组(10 mg/kg)以及TAT-CBD3低剂量组(3mg/kg)。制备大鼠阿尔茨海默病模型,模型成功后,尾静脉注射给药,连续给药15天,假手术组及模型组给予相同体积的生理盐水。末次给药后,Morris水迷宫进行大鼠行为学检测,HE染色检测大鼠海马CA1区神经元损伤,Western blot法检测相关蛋白表达 ...
姚远, 任晶红, 刘环宇, 纪影实
doaj
Research progress in the effect of nutritional intervention on cognitive impairment related to Alzheimer's disease [PDF]
, 2023 Alzheimer's disease (AD) is an age-related neurodegenerative disease with insidious onset and slow progression. The progression of AD from only brain pathological changes to clinically identifiable cognitive changes is affected by a variety of ...
HUANG Gaozhong, JIANG Xinting
core +1 more source
Zhongguo shiyan zhenduanxue, 2021 1细胞凋亡在阿尔茨海默病(AD)中的作用AD是一种常见的神经系统退行性疾病,其病理特征为β-淀粉样蛋白(Aβ)沉积,Tau蛋白高度磷酸化形成的神经纤维缠结(NFTs),以及大量神经元死亡导致大脑功能调控紊乱,从而出现严重的记忆认知障碍[1]。由于AD的具体发病机制尚不明确,目前临床上并没有成熟有效的治疗手段或者药物。
曾琳琳, 付学奇
doaj
PT109改善链脲佐菌素诱导的散发性阿尔茨海默病小鼠认知功能障碍的作用及机制 [PDF]
, 2021 目的观察PT109能否改善侧脑室注射链脲佐菌素（icv-STZ）诱导的散发性AD小鼠模型的认知功能障碍并对其机制进行初步探讨。方法32只7周龄雄性C57BL/6小鼠分为正常组（7只）、模型组（7只）、PT109低剂量组（9只）、PT109高剂量组（9只）。将STZ于第1和3天注射入小鼠侧脑室建立散发性阿尔茨海默病小鼠模型；（3mg/kg，每个注射位点5μL）造模后，分别腹腔注射PT109（30、100 mg·kg-1·d-1），2周后通过Morris水迷宫和避暗实验评价小鼠学习记忆能力；随后通过免疫荧光、
侯加卫 +5 more
core +1 more source
Trisomy 21-induced Dysregulation of Microglial Homeostasis in Alzheimer’s Brains is Mediated by USP25 [PDF]
, 2021 阿尔茨海默病（Alzheimer’s disease, AD）是一种最为常见的与记忆、认知能力退化相关的渐进性神经退行性疾病。唐氏综合征（Down’s syndrome, DS）是早发型阿尔茨海默病的一个重要风险因素，作为最常见的智力障碍遗传疾病，厦门大学医学院神经科学研究所王鑫教授团队揭示了治疗阿尔茨海默病和唐氏综合征新的治疗靶点，并且在小鼠模型上利用USP25小分子抑制剂成功地改善了阿尔茨海默病小鼠的认知功能，缓解了神经退行性病变的病理进程。该研究工作由王鑫教授指导完成 ...
Anjie Di +35 more
core +1 more source